IT1393875B1 - GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION - Google Patents

GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION

Info

Publication number
IT1393875B1
IT1393875B1 ITTO2009A000338A ITTO20090338A IT1393875B1 IT 1393875 B1 IT1393875 B1 IT 1393875B1 IT TO2009A000338 A ITTO2009A000338 A IT TO2009A000338A IT TO20090338 A ITTO20090338 A IT TO20090338A IT 1393875 B1 IT1393875 B1 IT 1393875B1
Authority
IT
Italy
Prior art keywords
glutathyate
antinfluenous
reductase
medication
peg conjugate
Prior art date
Application number
ITTO2009A000338A
Other languages
Italian (it)
Inventor
Gianfranco Merizzi
Giulia Federica Merizzi
Original Assignee
Medestea Res & Production S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medestea Res & Production S P A filed Critical Medestea Res & Production S P A
Priority to ITTO2009A000338A priority Critical patent/IT1393875B1/en
Priority to PCT/IB2010/051842 priority patent/WO2010125524A1/en
Publication of ITTO20090338A1 publication Critical patent/ITTO20090338A1/en
Application granted granted Critical
Publication of IT1393875B1 publication Critical patent/IT1393875B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
ITTO2009A000338A 2009-04-29 2009-04-29 GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION IT1393875B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITTO2009A000338A IT1393875B1 (en) 2009-04-29 2009-04-29 GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION
PCT/IB2010/051842 WO2010125524A1 (en) 2009-04-29 2010-04-28 A glutathione reductase-peg conjugate and the use thereof as an anti-influenza medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO2009A000338A IT1393875B1 (en) 2009-04-29 2009-04-29 GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION

Publications (2)

Publication Number Publication Date
ITTO20090338A1 ITTO20090338A1 (en) 2010-10-30
IT1393875B1 true IT1393875B1 (en) 2012-05-11

Family

ID=41351753

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO2009A000338A IT1393875B1 (en) 2009-04-29 2009-04-29 GLUTATHYATE REDUCTASE-PEG CONJUGATE AND ITS USE AS AN ANTINFLUENOUS MEDICATION

Country Status (2)

Country Link
IT (1) IT1393875B1 (en)
WO (1) WO2010125524A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312569B1 (en) * 1999-05-21 2002-04-22 Raffaele Ansovini USE OF GSSG ENZYME REDUCTED FOR THERAPEUTIC TREATMENT AND LAPROPHYLAXIS OF HIV-INFECTED PATIENTS.
JP4082505B2 (en) * 2003-03-06 2008-04-30 財団法人大阪産業振興機構 Alcohol analysis method

Also Published As

Publication number Publication date
WO2010125524A1 (en) 2010-11-04
ITTO20090338A1 (en) 2010-10-30

Similar Documents

Publication Publication Date Title
BRPI0907231A2 (en) pyrrolpyrimidines and pyrrolpyridines
BR112012004792A2 (en) surgical device and accessories.
BRPI0920521A2 (en) pharmaceutical combination
BRPI1008661A2 (en) aminopyrazine derivatives and remedies
BRPI0918652A2 (en) Pharmaceutical compositions and related release methods.
BRPI1010079A2 (en) composition and article
BR112012002247A2 (en) composition and article
BR112012001260A2 (en) epsilon-polylysine conjugates and their use
BRPI1016117A8 (en) isoxazole-isoxazole and isoxazole-isothiazole derivatives.
BR112012002877A2 (en) dilator and set.
BRPI0915822A2 (en) medical device
NO20083238L (en) Pacifier
DE112009000964A5 (en) tampon
BR112012010242A2 (en) heteroarylpiperidine and heteroarylpiperazine derivatives
BR112012007861A2 (en) medical devices and their pumps
BR112012000831A2 (en) related compounds, pharmaceutical compositions and methods
UY33111A (en) SYRINGES
DK2475649T3 (en) INDENONDERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPREHENSIVE SAME
BRPI1006293A2 (en) blocking differential mechanism and blocking differential
BR112012003860A2 (en) Combination and nutritional composition
DK2346559T3 (en) MEDICAL DEVICE
SE0900379L (en) legrests
FI20085626A0 (en) Short messaging estate
FR2937843B1 (en) MEDICAL PARAVENT
DK2310037T3 (en) CONGLUTIN-GAMMA AS-MEDICINE AND COST-SUPPLEMENT PATENT REQUIREMENTS